Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
debure c
(47 results)?
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27.
Lancet Child Adolesc Health. 2021.
PMID: 34715057
Free article.
Clinical Trial.
Gender-Affirming Care in Children.
DeZure C.
DeZure C.
Pediatr Ann. 2023 May;52(5):e160-e163. doi: 10.3928/19382359-20230307-03. Epub 2023 May 1.
Pediatr Ann. 2023.
PMID: 37159060
Item in Clipboard
Race-Based Medicine Is Racist.
DeZure C.
DeZure C.
Pediatr Ann. 2023 Oct;52(10):e365-e367. doi: 10.3928/19382359-20230829-05. Epub 2023 Oct 1.
Pediatr Ann. 2023.
PMID: 37820704
Item in Clipboard
COVID-19 Vaccines in Children.
DeZure C.
DeZure C.
Pediatr Ann. 2023 Jan;52(1):e4-e7. doi: 10.3928/19382359-20221114-02. Epub 2023 Jan 1.
Pediatr Ann. 2023.
PMID: 36625802
Item in Clipboard
Updated Clinical Practice Guidelines for Management of Hyperbilirubinemia in Infants Born at 35 Weeks or More Gestation.
DeZure C.
DeZure C.
Pediatr Ann. 2023 Dec;52(12):e436-e439. doi: 10.3928/19382359-20231016-07. Epub 2023 Dec 1.
Pediatr Ann. 2023.
PMID: 38049191
Item in Clipboard
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC; KIDCARE Multicenter Study Group; Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S.
Roberts SC, et al. Among authors: dezure c.
Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3.
Contemp Clin Trials. 2019.
PMID: 30840903
Free article.
Item in Clipboard
Cite
Cite